Valiant (002643) Stock Overview

Valiant Co.,Ltd. produces and sells chemical materials worldwide. The company provides liquid crystal monomers and intermediates; OLED monomers, intermediates, and finished materials; PI materials; PR materials; lithium battery additives, and other electronic chemicals. It offers molecular sieves for automobile exhaust purification, petrochemical industry, gas adsorption and separation field, and VOCS adsorption field; and catalysts for flue gas denitration and alkylation field of benzene series. In addition, the company offers API, pharmaceutical intermediates, pharmaceutical formulations, Chinese medicine derivatives, and nutrition and health foods; life science products related to drug development, genomics, proteomics, metabonomics, food safety analysis, etc.; and diagnostic reagent products used for the diagnosis of human diseases, such as AIDS, hepatitis, cancer, dengue, fever, cardiovascular and cerebrovascular diseases, etc., as well as for the detection of drug abuse, endocrine levels, and other human conditions. The company was formerly known as Yantai Valiant Fine Chemicals Co., Ltd. and changed its name to Valiant Co.,Ltd. in May 2015. Valiant Co.,Ltd. was founded in 1992 and is headquartered in Yantai, China.